John E. Mullinax, MD, FACS (@johnemullinaxmd) 's Twitter Profile
John E. Mullinax, MD, FACS

@johnemullinaxmd

Section Head, Surgical Oncology, Sarcoma Dept at Moffitt. APD of CGSO fellowship. Lab focused on Tcell-based #immunotherapy for #sarcoma. Tweets are my own.

ID: 4164078587

linkhttps://moffitt.org/providers/john-mullinax/ calendar_today11-11-2015 13:33:44

867 Tweet

801 Takipçi

775 Takip Edilen

Seth M. Pollack (@immunosarc) 's Twitter Profile Photo

We are looking for another #sarcoma medical oncologist!!!! Please reach out to me if you or some one you know is interested!!!!

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Watch now: Alex Lazarides, MD (Alexander Lazarides), joins Cosi Belloso for an engaging discussion on orthopedic oncology and advances in osseointegration. bit.ly/3JoHQHU

Watch now: Alex Lazarides, MD (<a href="/alexlazarides/">Alexander Lazarides</a>), joins Cosi Belloso for an engaging discussion on orthopedic oncology and advances in osseointegration. bit.ly/3JoHQHU
CTOS (@ctosociety) 's Twitter Profile Photo

#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows! Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)! Check topics and mentors 🧑‍🏫on the graphic⬇️

#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows!
Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)!
Check topics and mentors 🧑‍🏫on the graphic⬇️
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025 Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors: • Cancer Biology •

Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025
 
Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors:
• Cancer Biology
•
CTOS (@ctosociety) 's Twitter Profile Photo

🚨 Save the Date! 🚨 TARPSWG meets at #CTOS2025! 📅 Nov 12 | 🕗 8 AM–12 PM (EST) 📍 The Boca Raton – ADDISON BALLROOM Updates on new studies, collaboration & innovation in sarcoma research. Let’s drive progress together! 💪 #ClinicalTrials #OncologyResearch #TARPSWG

🚨 Save the Date! 🚨
<a href="/TARPSWG/">TARPSWG</a> meets at #CTOS2025!
📅 Nov 12 | 🕗 8 AM–12 PM (EST)
📍 The Boca Raton – ADDISON BALLROOM
Updates on new studies, collaboration &amp; innovation in sarcoma research.
Let’s drive progress together! 💪
#ClinicalTrials #OncologyResearch #TARPSWG
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Tomorrow at #SITC25: Daniel Abate-Daga, PhD shares that chimeric antigen receptor-engineered TIL (CAR-TIL) shows potent tumor recognition and greater tumor infiltration than conventional CAR-T cells. #MoffittSITC25 Society for Immunotherapy of Cancer

Tomorrow at #SITC25: Daniel Abate-Daga, PhD shares that chimeric antigen receptor-engineered TIL (CAR-TIL) shows potent tumor recognition and greater tumor infiltration than conventional CAR-T cells.

#MoffittSITC25 <a href="/sitcancer/">Society for Immunotherapy of Cancer</a>
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Live from #SITC25: Daniel Abate-Daga, PhD, shares that CAR-TIL demonstrates potent tumor recognition and superior infiltration compared with traditional CAR-T cells. Key takeaways: • Murine TIL concentrate in tumors after adoptive transfer and gradually acquire EM phenotype.

Live from #SITC25: Daniel Abate-Daga, PhD, shares that CAR-TIL demonstrates potent tumor recognition and superior infiltration compared with traditional CAR-T cells.

Key takeaways:
• Murine TIL concentrate in tumors after adoptive transfer and gradually acquire EM phenotype.
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Join Marine Potez, PhD at #SITC25 as she discusses the the feasibility and efficacy of TIL expansion from clear cell renal cell carcinoma to enhance TIL-based adoptive cell therapy. #MoffittSITC25 Society for Immunotherapy of Cancer

Join Marine Potez, PhD at #SITC25 as she discusses the the feasibility and efficacy of TIL expansion from clear cell renal cell carcinoma to enhance TIL-based adoptive cell therapy.

#MoffittSITC25 <a href="/sitcancer/">Society for Immunotherapy of Cancer</a>
John E. Mullinax, MD, FACS (@johnemullinaxmd) 's Twitter Profile Photo

Crushed to hear this news over the weekend. Such a tremendous loss for our sarcoma community and the patients he served. Thinking of his family now and we will press on in our work, in remembrance of him.

CTOS (@ctosociety) 's Twitter Profile Photo

Great opportunity for those who can not attend #CTOS2025 in person in Boca Raton or will be still on the way! You can join TARPSWG meeting online 👩‍💻

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025 Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors: • Cancer Biology •

Advance your career in #CancerResearch with the Moffitt Cancer PhD program! Application deadline: December 1, 2025
 
Are you passionate about fighting cancer? Our program prepares future scientists with a rigorous curriculum and offers four unique majors:
• Cancer Biology
•
Palma Dileo (@dileo_palma) 's Twitter Profile Photo

CTOS William Tap Herbert Loong, MBBS, FASCO Tom Wei-Wu Chen John E. Mullinax, MD, FACS Christina Roland, MD, MS Emily Keung, MD Robin Lewis Jones Lorenzo D'Ambrosio Sandra P D'Angelo, MD Sandro Pasquali It was a great start of the morning. Thank you to the mentors and experts for joining and sharing their insights and expertise. Most importantly thank you for the young colleagues for attending, engaging and ask challenging and important questions.

<a href="/ctosociety/">CTOS</a> <a href="/WTapMD/">William Tap</a> <a href="/herbloong/">Herbert Loong, MBBS, FASCO</a> <a href="/saxotomy/">Tom Wei-Wu Chen</a> <a href="/JohnEMullinaxMD/">John E. Mullinax, MD, FACS</a> <a href="/CrisyRoland/">Christina Roland, MD, MS</a> <a href="/emilykeungMD/">Emily Keung, MD</a> <a href="/RobinL_Jones/">Robin Lewis Jones</a> <a href="/DAmbrosio_MD/">Lorenzo D'Ambrosio</a> <a href="/sandrapdangelo/">Sandra P D'Angelo, MD</a> <a href="/sandro_pasquali/">Sandro Pasquali</a> It was a great start of the morning. Thank you to the mentors and experts for joining and sharing their insights and expertise. Most importantly thank you for the young colleagues for attending, engaging and ask challenging and important questions.
Ahmad Tarhini (@atarhinimdphd) 's Twitter Profile Photo

Our latest published article Nature Communications | Multicellular #immuneecotypes within #solidtumors as predictors of benefits & #immuneresistance w #immunecheckpoint inhibitors | Great collaborative effort across #ORIEN Network Xuefeng Wang Tingyi Li Moffitt Cancer Center nature.com/articles/s4146…

FloridaACS (@floridaacs) 's Twitter Profile Photo

Support Florida’s future surgical leaders this #GivingTuesday! Your donation funds two $2,500 travel awards for Florida’s own RAS-ACS and YFAACS members to represent Florida at 2026 American College of Surgeons meetings! Give today: bit.ly/4okp1Ei #FutureofSurgery #FCACS

Support Florida’s future surgical leaders this #GivingTuesday!

Your donation funds two $2,500 travel awards for Florida’s own <a href="/RASACS/">RAS-ACS</a> and <a href="/acsYFA/">YFAACS</a> members to represent Florida at 2026 <a href="/AmCollSurgeons/">American College of Surgeons</a> meetings!

Give today: bit.ly/4okp1Ei

#FutureofSurgery #FCACS